Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
出版年份 2012 全文链接
标题
Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 209, Issue 3, Pages 507-520
出版商
Rockefeller University Press
发表日期
2012-03-06
DOI
10.1084/jem.20111424
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling
- (2011) Helen M. Jopling et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
- (2011) K. Ballmer-Hofer et al. BLOOD
- Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis
- (2011) Masabumi Shibuya BMB Reports
- Transdifferentiation of glioblastoma cells into vascular endothelial cells
- (2011) Y. Soda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- Bevacizumab for Malignant Gliomas
- (2010) Fabio M. Iwamoto et al. ARCHIVES OF NEUROLOGY
- Autocrine regulation of glioblastoma cell-cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay
- (2010) Petra Knizetova et al. CELL CYCLE
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
- (2010) Sridharan Gururangan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2010) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction
- (2010) Ashley Jarvis et al. JOURNAL OF MEDICINAL CHEMISTRY
- CD133+ niches and single cells in glioblastoma have different phenotypes
- (2010) Karina Christensen et al. JOURNAL OF NEURO-ONCOLOGY
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
- (2009) Joost JC Verhoeff et al. BMC CANCER
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Down-regulation of Vascular Endothelial Growth Factor Receptor 2 Is a Major Molecular Determinant of Proteasome Inhibitor-Mediated Antiangiogenic Action in Endothelial Cells
- (2009) M. Meissner et al. CANCER RESEARCH
- Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1
- (2009) C. Folkins et al. CANCER RESEARCH
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face
- (2009) Wataru Tokuyama et al. HUMAN PATHOLOGY
- Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways
- (2009) Zhizhong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Rab27a and Rab27b control different steps of the exosome secretion pathway
- (2009) Matias Ostrowski et al. NATURE CELL BIOLOGY
- Antiangiogenic therapies for high-grade glioma
- (2009) Andrew D. Norden et al. Nature Reviews Neurology
- Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression
- (2009) A. HLOBILKOVA et al. NEOPLASMA
- Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
- (2009) F. M. Iwamoto et al. NEUROLOGY
- CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
- (2009) Yaojiong Wu et al. STEM CELLS AND DEVELOPMENT
- Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
- (2008) A. Desjardins et al. CLINICAL CANCER RESEARCH
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
- (2008) Kyeung Min Joo et al. LABORATORY INVESTIGATION
- IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS
- (2008) Alfred T. Ogden et al. NEUROSURGERY
- Precancerous Stem Cells Can Serve As Tumor Vasculogenic Progenitors
- (2008) Rulong Shen et al. PLoS One
- Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition
- (2008) Christine E. Eyler et al. STEM CELLS
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started